Nevertheless, the finding that CEBPD is a key TF for this process has important theoretical and clinical significance, because ECM-integrin interactions are important activators of the EGFR/PI3K pathway, and the EGFR/PI3K pathway is one of the core pathways altered in GBM [52]. The gene discussed is MMRN1; the disease is glioblastoma.